c-MET Antikörper (AA 743-932)
-
- Target Alle c-MET (MET) Antikörper anzeigen
- c-MET (MET) (Met Proto-Oncogene (MET))
-
Bindungsspezifität
- AA 743-932
-
Reaktivität
- Human, Affe
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser c-MET Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunocytochemistry (ICC)
- Immunogen
- Purified recombinant fragment of human MET (AA 743-932) expressed in E. Coli.
- Klon
- 5E9C4
- Isotyp
- IgG1
- Top Product
- Discover our top product MET Primärantikörper
-
anti-Met Proto-Oncogene (MET) (AA 25-150) antibody
MET Reaktivität: Human, Maus WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) (AA 1092-1379) antibodyMET Reaktivität: Human WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) antibodyMET Reaktivität: Human WB, ELISA, IHC, IF, FACS Wirt: Kaninchen Monoclonal 2D12 unconjugated Recombinant Antibody
anti-Met Proto-Oncogene (MET) (AA 743-932) antibodyMET Reaktivität: Human WB, ELISA, IHC, FACS, ICC Wirt: Maus Monoclonal 5E9B7 unconjugated
anti-Met Proto-Oncogene (MET) (C-Term) antibodyMET Reaktivität: Human WB, IF, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) (Internal Region) antibodyMET Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) (Tyr1003) antibodyMET Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) (AA 83-209) antibodyMET Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) (pTyr1349) antibodyMET Reaktivität: Human, Maus, Ratte WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Met Proto-Oncogene (MET) (pTyr1003) antibodyMET Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000, ICC: 1:200 - 1:1000, FCM: 1:200 - 1:400
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.05 % sodium azide
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- 4°C, -20°C for long term storage
-
- Target
- c-MET (MET) (Met Proto-Oncogene (MET))
- Andere Bezeichnung
- MET (MET Produkte)
- Synonyme
- AUTS9 antikoerper, HGFR antikoerper, RCCP2 antikoerper, c-Met antikoerper, AI838057 antikoerper, HGF antikoerper, Par4 antikoerper, Hgfr antikoerper, c-met antikoerper, MET antikoerper, C-MET antikoerper, met antikoerper, met-A antikoerper, MET proto-oncogene, receptor tyrosine kinase antikoerper, met proto-oncogene antikoerper, MET proto-oncogene, receptor tyrosine kinase L homeolog antikoerper, MET antikoerper, Met antikoerper, met.L antikoerper
- Hintergrund
- This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers.,
- Molekulargewicht
- 71.3kDa
- HGNC
- 6925
- Pathways
- RTK Signalweg, Carbohydrate Homeostasis, Synaptic Membrane, Signaling of Hepatocyte Growth Factor Receptor
-
